The HemeScreen BCR-ABL1 Panel enabled Precipio’s clinical lab to detect a co-expression of both p190 and p210 isoforms in this patient, leading to more informed care decisions.
Read More
The expiration of the federal Public Health Emergency for COVID-19 provides new impetus for lab innovation in the post-pandemic world.
Read More
Patients with chronic myeloid leukemia need regular BCR::ABL1 testing for the rest of their lives, which can translate into more lab work.
Read More
Investigators at Children’s Hospital Los Angeles investigators have developed a liquid biopsy for pediatric solid tumors.
Read More
Eurofins launched a test that can assess the expansion and persistence of CAR-T therapy in patients with certain leukemia and lymphomas.
Read More